Functional and cellular consequences of covalent target protein modification by furan in rat liver

Susanne Ramm1, Elisabeth Limbeck1, Angela Mally1

  • 1Department of Toxicology, University of Würzburg, 97078 Würzburg, Germany.

Toxicology
|July 13, 2016
PubMed

Insights

Furan exposure alters liver enzyme activity and metabolic pathways, impacting cellular functions. High furan doses disrupt glycolysis and mitochondrial function, while lower doses show no significant protein changes.

Area of Science:

  • Toxicology
  • Biochemistry
  • Molecular Biology

Background:

  • Furan hepatotoxicity is linked to its reactive metabolite, cis-2-butene-1,4-dial, binding to critical hepatic proteins.
  • Previous work identified 61 furan target proteins involved in metabolism, ATP synthesis, protein folding, and redox homeostasis.

Purpose of the Study:

  • To investigate the impact of furan on key enzyme activities in rat liver.
  • To link functional enzyme changes to alterations in cellular processes and understand furan toxicity pathways.

Main Methods:

  • Analysis of enzyme activities (thioredoxin 1, glyceraldehyde-3-phosphate dehydrogenase, enoyl-CoA hydratase, succinate dehydrogenase) in rat liver.
  • Measurement of mRNA expression and metabolic products (ketone bodies, TCA cycle metabolites).
  • Treatment of rats with single high-dose or repeated low-dose furan.

Main Results:

  • High-dose furan increased thioredoxin 1 (Txn1) activity and mRNA, inhibited glyceraldehyde-3-phosphate dehydrogenase, and altered glycolysis.
  • Furan treatment enhanced fatty acid utilization (increased enoyl-CoA hydratase activity, ketone body production) but reduced succinate dehydrogenase activity, indicating mitochondrial dysfunction.
  • Repeated low-dose furan administration did not cause significant changes in target protein function.

Conclusions:

  • Furan disrupts key metabolic pathways and mitochondrial function in the liver, particularly at high doses.
  • The study maps biological processes and toxicity pathways affected by furan, highlighting dose and time dependency.
  • Further research is needed to establish the contribution of these metabolic alterations to overall furan toxicity.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.5K